NDC 0409-5933

Daptomycin

Daptomycin

Daptomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira Inc.. The primary component is Daptomycin.

Product ID0409-5933_1e2552bd-f3f3-4c40-aaaa-eeef65a71b83
NDC0409-5933
Product TypeHuman Prescription Drug
Proprietary NameDaptomycin
Generic NameDaptomycin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-07-17
Marketing CategoryNDA / NDA
Application NumberNDA209949
Labeler NameHospira Inc.
Substance NameDAPTOMYCIN
Active Ingredient Strength350 mg/10mL
Pharm ClassesLipopeptide Antibacterial [EPC],Lipopeptides [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0409-5933-01

1 VIAL, GLASS in 1 CARTON (0409-5933-01) > 10 mL in 1 VIAL, GLASS
Marketing Start Date2020-10-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Daptomycin" or generic name "Daptomycin"

NDCBrand NameGeneric Name
0143-9378DaptomycinDaptomycin
0409-0106DaptomycinDAPTOMYCIN
0409-0120DaptomycinDAPTOMYCIN
0409-0122DaptomycinDAPTOMYCIN
0409-2757DaptomycinDAPTOMYCIN
0409-5933DaptomycinDaptomycin
0703-0125DaptomycinDaptomycin
0781-3295daptomycindaptomycin
16714-892DaptomycinDaptomycin
16729-434DaptomycinDaptomycin
16729-435DAPTOMYCINDaptomycin
25021-174daptomycindaptomycin
25021-179DaptomycinDaptomycin
70594-034DaptomycinDaptomycin
70594-053DaptomycinDaptomycin
63323-871DaptomycinDaptomycin
63323-371DaptomycinDaptomycin
67457-813daptomycindaptomycin
43598-413DaptomycinDaptomycin
68001-376DaptomycinDaptomycin
63323-585DaptomycinDaptomycin
71839-107daptomycindaptomycin
57884-3151DaptomycinDaptomycin
69097-807DaptomycinDaptomycin
72572-102DaptomycinDaptomycin
72572-100DaptomycinDaptomycin
45932-0039DaptomycinDaptomycin
71288-018DAPTOMYCINDAPTOMYCIN
76233-091DaptomycinDaptomycin
31722-102DaptomycinDaptomycin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.